Precision Dosing of Tacrolimus in Liver Transplantation: Integrating Donor‐Recipient CYP3A5 Pharmacogenomics and Drug Interactions
CPT: Pharmacometrics & Systems Pharmacology · 2026
DOI: 10.1002/psp4.70339 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2026. Verfasst von Virunya Komenkul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Liver Transplantation, Tacrolimus, Cytochrome P-450 CYP3A, Immunosuppressive Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund).
Abstract (Originalsprache)
Tacrolimus dosing in liver transplantation is complicated by a narrow therapeutic index and high CYP3A5 genetic variability. While saturable Michaelis–Menten kinetics can explain nonlinearities, identifying saturable parameters from routine clinical data remains challenging. This study aimed to determine the optimal structural model and develop a precision dosing algorithm. A population pharmacokinetic analysis was conducted in 114 patients, yielding 1989 observations. CYP3A5 genotypes were determined for both recipients and donors. Using Phoenix NLME, we rigorously compared linear versus Michaelis–Menten elimination structures. Stepwise covariate modeling was conducted to quantify the impact of genetic, physiological, and pharmacological factors, followed by Monte Carlo simulations to optimize dosing. A conventional two‐compartment model adequately described the data without requiring a Michaelis–Menten structure. The combined CYP3A5 genotype exhibited a distinct stepwise reduction in apparent clearance from the homozygous expressor to the non‐expressor group. Fluconazole emerged as a major inhibitor, reducing clearance by 33%, whereas prednisolone showed modest induction. Hemoglobin displayed a significant inverse relationship with clearance. Crucially, incorporating the daily dose as a covariate on clearance effectively captured the apparent nonlinear disposition. Simulations confirmed that fluconazole‐treated patients require substantially lower doses (1.5–3.0 mg every 12 h) compared with fluconazole‐free patients (2.5–7.0 mg every 12 h). A dose‐dependent two‐compartment model offers a basis for model‐informed dose selection, addressing reported nonlinearities through physiological covariates. We provide a model‐informed dosing algorithm that accounts for combined recipient/donor genetics and drug interactions, which may improve target attainment in liver transplant populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Department of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand.
- Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Excellence Center in Liver Diseases, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
- Department of Surgery, Faculty of Medicine, Chulalongkorn University & King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Department of Pathology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
ORCID-Profile: Virunya Komenkul, Prawat Chantharit, Piyawat Komolmit, Athaya Vorasittha, Anapat Sanpavat, Sirinporn Suksawatamnuay, Chandramouli Radhakrishnan, Thitima Wattanavijitkul
Förderung
- 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)
Zitieren
APA
Komenkul, V., Chantharit, P., Komolmit, P., Nonthasoot, B., Vorasittha, A., Sanpavat, A., Suksawatamnuay, S., Radhakrishnan, C., & Wattanavijitkul, T. (2026). Precision Dosing of Tacrolimus in Liver Transplantation: Integrating Donor‐Recipient CYP3A5 Pharmacogenomics and Drug Interactions. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70339
Vancouver
Komenkul V, Chantharit P, Komolmit P, Nonthasoot B, Vorasittha A, Sanpavat A, et al. Precision Dosing of Tacrolimus in Liver Transplantation: Integrating Donor‐Recipient CYP3A5 Pharmacogenomics and Drug Interactions. CPT: Pharmacometrics & Systems Pharmacology. 2026. doi:10.1002/psp4.70339
BibTeX
@article{Komenkul2026,
author = {Komenkul, Virunya and Chantharit, Prawat and Komolmit, Piyawat and Nonthasoot, Bunthoon and Vorasittha, Athaya and Sanpavat, Anapat and Suksawatamnuay, Sirinporn and Radhakrishnan, Chandramouli and Wattanavijitkul, Thitima},
title = {Precision Dosing of Tacrolimus in Liver Transplantation: Integrating Donor‐Recipient CYP3A5 Pharmacogenomics and Drug Interactions},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2026},
doi = {10.1002/psp4.70339}
}
EUVIMED